Woodline Partners LP Agios Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$27.55 - $48.83 $3.12 Million - $5.54 Million
113,378 New
113,378 $4.89 Million
Q3 2021

Nov 15, 2021
SELL
$41.92 - $58.18 $6.59 Million - $9.15 Million
-157,191 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$52.06 - $61.27 $34.7 Million - $40.9 Million
-666,906 Reduced 80.93%
157,191 $8.66 Million
Q1 2021

May 17, 2021
BUY
$44.23 - $57.5 $36.4 Million - $47.4 Million
824,097 New
824,097 $42.6 Million

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email